Prof. Erika Lietzan

Professor Lietzan Speaks at Food & Drug Law Institute’s Annual Conference

May 9th, 2018

On May 4, Professor Erika Lietzan participated in the perennially popular closing session – on significant litigation in 2017 and cases to watch in 2018 – of the Food &…

Professor Lietzan Featured on Webcast about New Uses for Established Drugs

April 5th, 2018

On March 29, Professor Erika Lietzan was the featured speaker in a webcast from the Syracuse College of Law’s IP Tech Law Center.  She spoke with Shubha Ghosh about ensuring…

Professor Lietzan Speaks About FDA Regulation of Direct-to-Consumer Genetic Testing

March 16th, 2018

Professor Erika Lietzan spoke on March 16 at “Frontiers in Precision Medicine III: Will Personalized Medicine Improve Population Health?” –  a full day symposium hosted by the University of Utah…

Professor Lietzan Speaks at Conference about New Uses of Established Drugs

February 14th, 2018

On February 8, Professor Erika Lietzan spoke at the conference, “Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs,” convened in Washington, DC, by University College London (UCL) and…

Professor Lietzan Presents Research Examining Impact of Pharmaceutical Regulation

January 4th, 2018

In December, Professor Erika Lietzan spoke at a pharmaceutical law conference hosted by the CREDIMI, a center for research relating to markets and international investment, at the school of law…